Ernexa Therapeutics (ERNAW) FCF Margin (2010 - 2024)
Ernexa Therapeutics' (ERNAW) quarterly FCF Margin came in at 18652.63% in Q4 2024, down 1504243.0% YoY from N/an in Q1 2024, and down 1430.81% on a QoQ basis from 1218.48% in Q3 2024.
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) FCF Margin (2010 - 2024) Analysis & Trends
Ernexa Therapeutics (ERNAW) has 13 years of FCF Margin data on file, last reported at 18652.63% in Q4 2024.
- Quarterly FCF Margin fell 1504243.0% year-over-year to 18652.63% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 2639.0% (up 1778800.0% YoY) and the FY2024 annual result came in at 2639.0%, up 1778800.0% from the prior year.
- FCF Margin declined to 18652.63% in Q4 2024, from 1218.48% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 78.43% in Q1 2020 to a low of 18652.63% in Q4 2024.
- A 3-year average of 5952.39% and a median of 3610.2% in 2023 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 1496975 bps in 2024, down 1504243 bps in 2024.
- Tracing ERNAW's FCF Margin over 3 years: stood at 137.15% in 2020, then tumbled by 2532 bps to 3610.2% in 2023, then plunged by 417 bps to 18652.63% in 2024.
- The last three FCF Margin figures came in at 18652.63% (Q4 2024), 1218.48% (Q3 2024), and 5336.17% (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -18,657.89% |
| Sep 30, 2024 | -1,294.46% |
| Jun 30, 2024 | -5,336.17% |
| Mar 31, 2024 | -8,187.23% |
| Dec 31, 2023 | -1,502.04% |
| Sep 30, 2023 | -16,188.24% |
| Dec 31, 2020 | -140.47% |
| Sep 30, 2020 | -162.94% |
| Mar 31, 2020 | -78.43% |
| Dec 31, 2019 | 17.40% |
| Sep 30, 2019 | 3.91% |
| Jun 30, 2019 | 5.26% |
| Mar 31, 2019 | 8.80% |
| Dec 31, 2018 | 9.51% |
| Sep 30, 2018 | 0.38% |
| Jun 30, 2018 | 2.44% |
| Mar 31, 2018 | -5.61% |
| Dec 31, 2017 | -12.71% |
| Sep 30, 2017 | -37.51% |
| Jun 30, 2017 | 55.18% |